MAPK9 and urinary bladder neoplasm: In patients who underwent transurethral resection of bladder tumor (TURBT), the mean recurrence-free survival time of the lower JNK2 expression group was 37.2±4.2 months, which was lower than the higher JNK2 expression group (41.7±2.6months); however, there was no statistical significance (p=0.182, Log-rank test) (Figure 5b).